by Sue Robbins | Feb 4, 2021 | Migraine
Migraine is a neurological condition that affects nearly 40 million people in the United States. Migraine attacks often occur on one side of the head. They may sometimes be preceded or accompanied by visual or sensory disturbances known as an aura. Other symptoms,...
by Sue Robbins | Feb 2, 2021 | Migraine, Migraine
Overview At the age of 23, I had a four-year-old, a 15-month-old and a newborn. My last pregnancy catapulted my migraine into the early stages of becoming chronic. With three very small children and a new form of migraine that I was not familiar with, I felt extremely...
by Sue Robbins | Jan 31, 2021 | Migraine
Mindfulness Training Does Not Reduce Migraine Frequency However, mindfulness-based stress reduction improves various measures, including disability and quality of life WEDNESDAY, Jan. 6, 2021 (HealthDay News) — Mindfulness-based stress reduction (MBSR) does not...
by Sue Robbins | Jan 27, 2021 | Migraine
US-Israeli prescribed digital therapeutics firm Theranica, a company that develops advanced electroceuticals for migraine and other pain conditions, announced on Monday that its Nerivio therapeutic device has received clearance from the US Food and Drug Administration...
by Sue Robbins | Jan 26, 2021 | Miscellaneous
Researchers found that levels of a nerve growth factor were lower in people with depression or bipolar disorder than in healthy controls. Doctors could potentially use levels of the growth factor to monitor the effects of antidepressant treatment. In adults, a protein...
